Evidence map›Paper›PMID 37556531›Full record

ArticleScience advances2023

Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.

Jonathan F Thomas, Marco Igor Valencia-Sánchez, Simone Tamburri, Susan L Gloor, Samantha Rustichelli, Victoria Godínez-López, Pablo De Ioannes, Rachel Lee, Stephen Abini-Agbomson, Kristjan Gretarsson and 17 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Substrate biasing in UCHL5 proteoforms.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reassessing BenignGenes · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Epigenetic alterations in Myeloid Malignancies.Advances in experimental medicine and biology · 2026
    Review
  15. Article
  16. Article
  17. Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025
    Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 2 countries.

Jonathan F ThomasDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Marco Igor Valencia-SánchezDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0002-7199-4546
Simone TamburriDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
Susan L GloorEpiCypher Inc., Durham, NC 27709, USA.ORCID 0000-0001-6911-395X
Samantha RustichelliDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
Victoria Godínez-LópezDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Pablo De IoannesDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0003-1944-3912
Rachel LeeDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0003-2501-5973
Stephen Abini-AgbomsonDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Kristjan GretarssonDepartment of Genetics and Development and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0002-9616-416X
Jonathan M BurgEpiCypher Inc., Durham, NC 27709, USA.
Allison R HickmanEpiCypher Inc., Durham, NC 27709, USA.ORCID 0009-0007-7901-6687
Lu SunEpiCypher Inc., Durham, NC 27709, USA.ORCID 0000-0003-2991-2065
Saarang GopinathEpiCypher Inc., Durham, NC 27709, USA.
Hailey F TaylorEpiCypher Inc., Durham, NC 27709, USA.
Zu-Wen SunEpiCypher Inc., Durham, NC 27709, USA.
Ryan J EzellEpiCypher Inc., Durham, NC 27709, USA.
Anup VaidyaEpiCypher Inc., Durham, NC 27709, USA.
Matthew J MeinersEpiCypher Inc., Durham, NC 27709, USA.
Marcus A CheekEpiCypher Inc., Durham, NC 27709, USA.
William J RiceDepartment of Cell Biology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0002-5187-255X
Vladimir SvetlovDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0002-1977-4271
Evgeny NudlerDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0002-8811-3071
Chao LuDepartment of Genetics and Development and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0003-0982-8122
Michael-Christopher KeoghEpiCypher Inc., Durham, NC 27709, USA.ORCID 0000-0002-2219-8623
Diego PasiniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.ORCID 0000-0002-9879-6486
Karim-Jean ArmacheDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0002-0890-9513
EpiCypher (United States) · USNew York University · USColumbia University Irving Medical Center · USHoward Hughes Medical Institute · USUniversity of Milan · ITEuropean Institute of Oncology · IT

Funding

Structural and functional analysis of gene silencingR01GM115882 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARMACHE, KARIM JEAN · 2015 to 2023
$3.4M
Molecular basis for aberrant de novo DNA methylation in cancerR01CA266978 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Karim Jean Armache, Chao Lu · 2022 to 2026
$2.6M
Regulation and Function of Histone H3K36 Methylation in Mammalian ChromatinR35GM138181 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LU, CHAO · 2020 to 2024
$2.0M
Novel enzyme inhibitor screening platform using modified designer nucleosomesR44GM119893 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2019 to 2020
$1.9M
NCI NIH HHS R01 CA266978NIGMS NIH HHS R01 GM115882NIGMS NIH HHS R35 GM138181NIGMS NIH HHS R44 GM119893
6 · The paper itself

Abstract

Histone H2A lysine 119 (H2AK119Ub) is monoubiquitinated by Polycomb repressive complex 1 and deubiquitinated by Polycomb repressive deubiquitinase complex (PR-DUB). PR-DUB cleaves H2AK119Ub to restrict focal H2AK119Ub at Polycomb target sites and to protect active genes from aberrant silencing. The PR-DUB subunits (BAP1 and ASXL1) are among the most frequently mutated epigenetic factors in human cancers. How PR-DUB establishes specificity for H2AK119Ub over other nucleosomal ubiquitination sites and how disease-associated mutations of the enzyme affect activity are unclear. Here, we determine a cryo-EM structure of human BAP1 and the ASXL1 DEUBAD in complex with a H2AK119Ub nucleosome. Our structural, biochemical, and cellular data reveal the molecular interactions of BAP1 and ASXL1 with histones and DNA that are critical for restructuring the nucleosome and thus establishing specificity for H2AK119Ub. These results further provide a molecular explanation for how >50 mutations in BAP1 and ASXL1 found in cancer can dysregulate H2AK119Ub deubiquitination, providing insight into understanding cancer etiology.

Indexed as

Drosophila ProteinsNeoplasmsHistonesHumansLysineNucleosomesPolycomb-Group ProteinsRepressor ProteinsTumor Suppressor ProteinsUbiquitin ThiolesteraseASXL1 protein, humanBAP1 protein, humanDrosophila ProteinsHistonesLysineNucleosomesPolycomb-Group ProteinsRepressor ProteinsTumor Suppressor ProteinsUbiquitin Thiolesterase

Identifiers

PMID37556531
PMCPMC10411902
OpenAlexW4385693727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.